Anlon Healthcare

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01017
  • NSEID: AHCL
  • BSEID: 544497
INR
111.90
3.7 (3.42%)
BSENSE

Mar 05

BSE+NSE Vol: 3.0 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 80.65% vs -41.01% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 108.32% vs 24.54% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -5.48% vs 3.50% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 112.46% vs 65.93% in Mar 2024

Compare Profit and Loss Results of Anlon Healthcare
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
120.00
271.00
-151.00
-55.72%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
120.00
271.00
-151.00
-55.72%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-1.00
4.00
400.00%
Raw Materials Consumed
71.00
159.00
-88.00
-55.35%
Power & Fuel Cost
2.00
8.00
-6.00
-75.00%
Employee Cost
4.00
30.00
-26.00
-86.67%
Operating Expenses
2.00
12.00
-10.00
-83.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
9.00
-8.00
-88.89%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
2.00
-1.00
-50.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
88.00
232.00
-144.00
-62.07%
Operating Profit (PBDIT) excl Other Income
32.00
38.00
-6.00
-15.79%
Other Income
0.00
5.00
-5.00
-100.00%
Operating Profit (PBDIT)
32.00
44.00
-12.00
-27.27%
Interest
3.00
3.00
0.00
0.00%
Profit before Depriciation and Tax
28.00
40.00
-12.00
-30.00%
Depreciation
1.00
4.00
-3.00
-75.00%
Profit Before Taxation & Exceptional Items
26.00
35.00
-9.00
-25.71%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
26.00
35.00
-9.00
-25.71%
Provision for Tax
6.00
8.00
-2.00
-25.00%
Profit After Tax
20.00
26.00
-6.00
-23.08%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
2.00
99.00
-97.00
-97.98%
Profit Available for appropriations
22.00
126.00
-104.00
-82.54%
Appropriations
22.00
126.00
-104.00
-82.54%
Equity Dividend (%)
0%
30%
-30.00
Earnings Per Share
6.37
5.57
0.80
14.36%
Profit And Loss - Net Sales
Net Sales 120.29 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 80.65% vs -41.01% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 32.21 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 108.32% vs 24.54% in Mar 2024

Profit And Loss - Interest
Interest 3.72 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -5.48% vs 3.50% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 20.52 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 112.46% vs 65.93% in Mar 2024